6th Annual Meeting of the International MS Cognition Society (IMSCOGS)

Wednesday 7 & Thursday 8 June 2017
Hotel Nikko, Düsseldorf

The International MS Cognition Society (IMSCOGS), founded in 2011, aims at bringing together researchers and clinicians who are engaged in the care of MS patients and who have a special interest in cognition. With its Annual Meetings IMSCOGS offers an international platform for discussions on a highly relevant topic which is still underestimated and underrepresented at other conferences.

The target audience for the conference includes neurologists, neuropsychologists, clinical psychologists,  neuroradiologists, neuroscientists, nursing professionals, rehabilitation specialists, and other related healthcare professionals. The conference especially encourages young researchers and clinicians to attend and present current work related to the context of the session topics.

Besides poster and platform presentations the 6th Annual Meeting will hold debate sessions where leading experts will identify areas of uncertainties and refer to open questions in the field. Thus the 2-day conference will be of high educational value to participants and will offer the opportunity to critically discuss views between practitioners and researchers.

The 6th Annual Meeting of the International MS Cognition Society will take place in Düsseldorf, Germany on June 7-8, 2017. The conference hotel is the Hotel Nikko in the heart of the city of Düsseldorf.

Meeting highlights

  • Two full conference days (Wednesday and Thursday)
  • Conference dinner at the former Franciscan Monastery Maxhaus (included in the registration fee)
  • Coffee breaks and luncheon
  • Accredited program for all participants
  • Conference abstracts will be published in Multiple Sclerosis Journal (MSJ)

The chairs of the IMSCOGS Conference Organizing Committee, Prof. Iris-Katharina Penner and Prof. Hans-Peter Hartung, look forward to welcoming you what promises to be an exciting event.  

CONFERENCE AGENDA

07:30-09:00 Registration
09:00-09:15

Welcoming address and opening remarks

I.-K. Penner, PhD & H.P. Hartung, MD, Conference Chairs

R. Benedict, PhD, President, IMSCOGS

09:15-11:00

Session 1 – Pathophysiology

Chairs:
H.P. Hartung, MD, Düsseldorf, DEU
F. Fazekas, MD, Graz, AUT

Debate session
(60 min)

Focal versus diffuse tissue damage

Debate on the contribution of different pathophysiologic aspects on cognitive impairment in MS


Speaker position: Pro focal damage: C. Enzinger, MD, Graz, AUT

Speaker position: Pro diffuse damage: J.J.G Geurts, MD, Amsterdam, NLD

Synthesis by Chairs

Selected presentations
(45 min)

selected papers from submitted abstracts

11:00-11:30 Coffee break
11:30-13:15

Session 2 – Brain Imaging

Chairs:
I.-K. Penner, PhD, Düsseldorf, DEU
C. Enzinger, MD, Graz, AUT

Debate session
(60 min)

Do structural or functional outcome measures most accurately reflect cognitive status?

Debate on different methodological approaches


Speaker position: Structure: F. Paul, MD, Berlin, DEU

Speaker position: Function: J. DeLuca, PhD, West Orange, NY, USA

Synthesis by Chairs

Selected presentations
(45 min)

selected papers from submitted abstracts

13:15-14:15 Lunch and poster viewing
14:15-16:00

Session 3 – Assessment

Chairs:

M. P. Amato, MD, Florence, ITA
H. Schreiber, MD, Ulm, DEU

Key note lecture
(30 min incl. discussion)

Relevance and feasibility of neuropsychological assessment in clinical routine

Speaker: D.W. Langdon, PhD, London, GBR

Key note lecture
(30 min including discussion)

Neuropsychological testing and NEDA: Measuring progression and changes during relapse

Speaker: R. Benedict, PhD, Buffalo, USA

Selected presentations
(45 min)

selected papers from submitted abstracts

16:00-16:30 Coffee break
16:30-18:15

Session 4 – Pharmacological Treatment

Chairs:
O. Aktas, MD, Düsseldorf, DEU
L. Krupp, MD, New York, NY, USA

Key note lecture
(30 min incl. discussion)

Is there evidence that MS drugs may help in treating cognitive deficits in MS?

Speaker: I.-K. Penner, PhD, Düsseldorf, DEU

Key note lecture
(30 min including discussion)

Is there evidence that symptomatic pharmacotherapy may help in treating cognitive deficits in MS?

Speaker: S. Fredrikson, MD, Stockholm, SWE

Selected presentations
(45 min)

selected papers from submitted abstracts

19:30 Conference Dinner at Maxhaus
08:00-09:00 Registration
09:00-10:45

Session 5 – Cognitive Profiles

Chairs:
S. Fredrikson, MD, Stockholm, SWE
P. Albrecht, MD, Düsseldorf, DEU

Key note lecture
(30 min incl. discussion)

Cognitive profiles in CIS/RIS, RRMS and SPMS

Speaker: B. Brochet, MD, Bordeaux, FRA

Key note lecture
(30 min incl. discussion)

Neurophysiological correlates of cognitive disturbances in CIS/RIS, RRMS and SPMS

Speaker: L. Leocani, MD, Milan, ITA

Selected presentations
(45 min)

selected papers from submitted abstracts

10:45-11:15 Coffee break
11:15-13:00

Session 6 – Cognitive Rehabilitation

Chairs:
K. Hellwig, MD, Bochum, DEU
J. DeLuca, PhD, West Orange, NY, USA

Debate session
(60 min)

Cognitive rehabilitation should be offered to each patient with cognitive problems

Debate on evidence of efficacy

Speaker position YES: P. Hämäläinen, PhD, Masku, FIN

Speaker position NO: F. Fazekas, MD, Graz, AUT

Synthesis by Chairs

Selected presentations
(45 min)

selected papers from submitted abstracts

13:00-14:00 Lunch and poster viewing
14:00-15:45

Session 7 - Pediatric MS

Chairs:
M. Falautano, PhD, Milan, ITA
D.W. Langdon, PhD, London, GBR

Key note lecture
(30 min incl. discussion)

Assessment of cognitive deficits in pediatric MS

Speaker: M.P. Amato, MD, Florence, ITA

Key note lecture
(30 min including discussion)

Treatment of cognitive deficits in pediatric MS

Speaker: L. Krupp, MD, New York,NY, USA

Selected presentations
(45 min)

selected papers from submitted abstracts

15:45-16:45

Session 8 – New and emerging areas

Chairs:
F. Paul, MD, Berlin, DEU
I.-K. Penner, PhD, Düsseldorf, DEU

Teaser lectures
(20 min)

Personality traits in MS

Speaker: H. Schreiber, MD, Ulm, DEU

 

Social cognition and ToM

Speaker: S.M. Gold, PhD, Berlin, DEU

 

Measuring cognitive impairment in the aged MS patient: Can we detect MCI/AD?

Speaker: R. Benedict, PhD, Buffalo, NY, USA

16:45-17:00 Closing remarks and invitation to Berlin 2018